Developing stroke care for adults in the community: rehabilitation through conductive education

Conductive education as a method of post-stroke rehabilitation: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN84064492

Enrollment

120

Registered

2011-03-04

Start date

2010-04-01

Completion date

Unknown

Last updated

2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke rehabilitation Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

The conductive education intervention will be administered as a 1.5 hour session once per week for 10 weeks. Intervention takes place in a small group setting (maximum of 5 participants) led by two co

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who have suffered a stroke and are in the post-acute stage of recovery 2. Participants should be medically well enough to follow the programme and be capable of giving informed consent. 3. Male or female, age = 18 years

Exclusion criteria

Exclusion criteria: 1. Individuals who are medically unfit to participate or unable to give informed consent 2. Participants must not be receiving regular physiotherapy input

Design outcomes

Primary

Measure	Time frame
1. Mobility will be assessed using a timed up and go test and a 10 metre walking test: The timed up and go test requires participants to stand from a chair, walk forward 3 metres, turn around, return to the chair and sit down. Completion time (in seconds) is recorded. The 10 metre walking test requires the participant to walk forwards 10m at their normal pace, and completion time (seconds) is recorded. 2. Activities of daily living will be measured using the Barthel Index: A 10 item questionnaire examining activities such as walking and dressing. Higher scores represent greater functional independence. 3. Quality of life will be measured using the Stroke Impact Scale: A 59-item stroke-specific questionnaire covering 8 domains of well-being. Higher scores indicate better well-being. 4. Participants are also asked to complete the EQ-5D quality of life scale for use in an economic evaluation linked to the study All measures are taken at baseline (before commencing the intervention/wait period), after 3 months (on completion of the intervention/waiting list period) and at follow up 3 months after intervention. Waiting list participants are also assessed on completion of the CE course.	—

Measure

Time frame

1. Mobility will be assessed using a timed up and go test and a 10 metre walking test: The timed up and go test requires participants to stand from a chair, walk forward 3 metres, turn around, return to the chair and sit down. Completion time (in seconds) is recorded. The 10 metre walking test requires the participant to walk forwards 10m at their normal pace, and completion time (seconds) is recorded. 2. Activities of daily living will be measured using the Barthel Index: A 10 item questionnaire examining activities such as walking and dressing. Higher scores represent greater functional independence. 3. Quality of life will be measured using the Stroke Impact Scale: A 59-item stroke-specific questionnaire covering 8 domains of well-being. Higher scores indicate better well-being. 4. Participants are also asked to complete the EQ-5D quality of life scale for use in an economic evaluation linked to the study All measures are taken at baseline (before commencing the intervention/wait period), after 3 months (on completion of the intervention/waiting list period) and at follow up 3 months after intervention. Waiting list participants are also assessed on completion of the CE course.

—

Secondary

Measure	Time frame
1. Cognitive performance will be measured using the following: 1.1. Test of Everyday Attention, which tests selective, sustained and divided attention 2. Wisconsin Card Sorting Test (WCST-64 version), a measure of planning, problem solving and cognitive flexibility. 2. Anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS): A 14-item questionnaire. Higher scores indicate higher levels of anxiety and depression. 3. Carers will be asked to complete the following at each assessment point: 3.1. SF-36, a general health-related quality of life measure 3.2. HADS All measures are taken at baseline (before commencing the intervention/wait period), after 3 months (on completion of the intervention/waiting list period) and at follow up 3 months after intervention. Waiting list participants are also assessed on completion of the CE course.	—

Measure

Time frame

1. Cognitive performance will be measured using the following: 1.1. Test of Everyday Attention, which tests selective, sustained and divided attention 2. Wisconsin Card Sorting Test (WCST-64 version), a measure of planning, problem solving and cognitive flexibility. 2. Anxiety and depression will be measured using the Hospital Anxiety and Depression Scale (HADS): A 14-item questionnaire. Higher scores indicate higher levels of anxiety and depression. 3. Carers will be asked to complete the following at each assessment point: 3.1. SF-36, a general health-related quality of life measure 3.2. HADS All measures are taken at baseline (before commencing the intervention/wait period), after 3 months (on completion of the intervention/waiting list period) and at follow up 3 months after intervention. Waiting list participants are also assessed on completion of the CE course.

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026